- Home
- LOOP vs ELUT Comparison
LOOP vs ELUT Comparison
Compare LOOP & ELUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LOOP | ELUT |
|---|---|---|
| Founded | 2010 | 2015 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Medical Specialities |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 39.7M | 42.5M |
| IPO Year | 2010 | 2020 |
Fundamental Metrics
Financial Performance| Metric | LOOP | ELUT |
|---|---|---|
| Price | $0.64 | $0.84 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $6.00 |
| AVG Volume (30 Days) | ★ 76.5K | 52.0K |
| Earning Date | 05-28-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 27.27 | ★ 146.77 |
| EPS | ★ N/A | N/A |
| Revenue | $10,889,000.00 | ★ $12,293,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $174.82 | $10.83 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 7016.99 | N/A |
| 52 Week Low | $0.64 | $0.50 |
| 52 Week High | $1.99 | $2.50 |
Technical Indicators
Market Signals| Indicator | LOOP | ELUT |
|---|---|---|
| Relative Strength Index (RSI) | 33.37 | 33.79 |
| Support Level | N/A | $0.51 |
| Resistance Level | $0.97 | $1.13 |
| Average True Range (ATR) | 0.08 | 0.07 |
| MACD | -0.00 | -0.01 |
| Stochastic Oscillator | 0.84 | 16.70 |
Price Performance
Historical ComparisonAbout LOOP Loop Industries Inc.
Loop Industries Inc is a technology company whose mission is to accelerate the world's shift toward sustainable PET plastic and polyester fiber and away from dependence on fossil fuels. Loop Industries owns patented and proprietary technology that depolymerizes no and low-value waste PET plastic and polyester fiber, including plastic bottles, packaging, and textiles such as carpets and clothing, into its base building block monomers, DMT and MEG.
About ELUT Elutia Inc.
Elutia Inc develops proprietary drug-eluting biomatrix products for use in surgical reconstruction and related applications. These products are designed to improve the interaction between implanted medical devices and patients. Its products include CanGaroo, designed for implantable electronic devices, and SimpliDerm, used in soft tissue repair, with functions related to implant support and wound management. The company operates in two segments: Women's Health and Cardiovascular. The majority of revenue is derived from the Women's Health segment.